Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)

NCT04432272 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT04432272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04432272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)
Lead sponsor
Corewell Health East
Phase
Phase 2
Overall status
Terminated
Start date
July 16, 2020
Completion date
November 28, 2020
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infections, covid-19, severe acute respiratory syndrome (sars)